PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 11 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
The derivative ethyl N-docosanoylanthranilate inhibited the growth of these pathogenic fungi [PMID:9611826]
Evidence summary
PubMed sources
- 1.PMID: 40871475 (2025) — Defining Phytochemical Metabolomes of Somatic Hybrids Gentiana cruciata L. (+) G. tibetica King ex Hook.f. (Gentianaceae) Using UHPLC-DAD-ESI-MS3 Analysis in Comparison to the Parental Species. · Molecules (Basel, Switzerland)
- 2.PMID: 33457807 (2020) — The complete chloroplast genome of Mitrasacme pygmaea (Loganiaceae). · Mitochondrial DNA. Part B, Resources
- 3.PMID: 9611826 (1998) — Secoiridoid glycosides and an antifungal anthranilate derivative from Gentiana tibetica. · Phytochemistry